REPROCELL (TYO: 4978) today announced the launch of its US FDA compliant Good Manufacturing Practice (GMP) Master Cell Bank (MCB) manufacturing service for human induced pluripotent stem cells (iPSCs) ...

Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...

Creative Biolabs launches expanded iPSC and astrocyte differentiation services to support next‑generation disease modeling and neurobiology research.

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, public reviews, and a provisional response from the authors. In this manuscript, ...

Besides convenience, one of the main benefits of self-driving cars is supposed to be safety. Yet in a bizarre move, Waymo — whose self-driving cabs had been enjoying extraordinary safety metrics — has ...

Creative Biolabs has upgraded its mRNA technology platform to provide integrated solutions for therapeutic development and induced pluripotent stem cell reprogramming, accelerating advancements in ...